KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL;경북대학교 산학협력단;KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION;경북대학교병원
发明人:
KIM, Hong Kyun,김홍균
申请号：
KRKR2019/005053
公开号：
WO2019/212199A1
申请日:
2019.04.26
申请国别(地区):
KR
年份:
2019
代理人:
摘要：
The present invention relates to a composition for preventing or treating inflammatory ocular surface diseases, and the composition does not cause side effects induced by steroidal drugs and has effects of tear secretion, corneal cell recovery and the inhibition of inflammatory cytokine expression, thereby being effectively used in the prevention or treatment of inflammatory ocular surface diseases such as dry eye syndrome.La présente invention concerne une composition pour prévenir ou traiter des maladies inflammatoires de la surface oculaire, et la composition ne cause pas d'effets secondaires induits par des médicaments stéroïdiens et a des effets de sécrétion lacrymale, de récupération de cellules cornéennes et d'inhibition de l'expression de cytokines inflammatoires, ce qui permet de l'utiliser efficacement dans la prévention ou le traitement de maladies inflammatoires de surface oculaire telles que le syndrome de l'œil sec.본 발명은 염증성 안구표면질환의 예방 또는 치료용 조성물에 관한 것으로, 상기 조성물은 스테로이드성 약물이 나타내는 부작용을 유발하지 않으며, 눈물 분비, 각막 세포 회복 및 염증성 사이토카인의 발현을 억제하는 효과가 있으므로, 안구건조증 등의 염증성 안구표면질환의 예방 또는 치료에 유용하게 활용할 수 있다.
